ClinicalTrials.gg
Not yet recruitingNCT07544550FAIRChairUpdated Apr 27, 2026

Rocking Chairs as Post-operative Treatment for Older Adults After Hip Surgery

An interventional study of Active rocking in a rocking chair and Sitting upright in a stationary chair in Postoperative Care, sponsored by University of Missouri, Kansas City. Not yet recruiting. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-04-27.

Sponsored by University of Missouri, Kansas City · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Feasibility and acceptability randomized controlled trial exploring the use of a rocking chair after a total hip arthroplasty in adults who are aged 65 or older. Primary aims include its feasibility and acceptability; exploratory aims include the impact of rocking on pain, gastrointestinal effects, anxiety, ambulation, and additional healthcare visits.

02

Conditions studied

  • Postoperative Care

Keywords

  • older adults
  • hip arthroplasty
  • rocking chair
  • feasiblity
  • acceptability
  • recovery
  • intervention
03

In context

Lead sponsor

University of Missouri, Kansas City is the lead sponsor of 48 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • scheduled to undergo an elective primary total hip arthroplasty
  • Weigh less than 163kg (limit of rocking chair)
  • Able to consent
  • Able to rock with at least one leg

Exclusion criteria

Exclusion Criteria:

  • Unable to sit in a chair for at least 30 minutes at a time
  • Hospitalized more than 24 hours after surgery
  • Cannot read and understand the English language
  • Planned disposition to rehabilitation facility or skilled nursing facility
  • Known vestibular dysfunction (such as Menieres, traumatic brain injury, vertigo)
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Intervention Group

    Rocking chair intervention

    Behavioral: Active rocking in a rocking chair

  • Active comparator
    Attention Control Group

    Sitting upright in stationary chair

    Behavioral: Sitting upright in a stationary chair

Interventions

  • BehavioralActive rocking in a rocking chair

    Participants will actively rock 3 times per day for 30 minutes in a rocking chair

    Also known as: Rocking

  • BehavioralSitting upright in a stationary chair

    Participants will sit upright in a stationary chair 3 times per day for 30 minutes

    Also known as: Sitting

06

What researchers measure

Primary outcomes

  1. Number of participants that enroll and complete study assessed by Feasibility Participant Questionnaire (developed by investigators)

    Feasibility of active rocking post-operative measured by total number of participants enrolled, total percentage and number completing the study, and percent of missing data. A higher percent of missing data is a negative outcome.

    Time frame: From enrollment to 31-day follow-up

  2. Total participants reporting acceptability of rocking or sitting as measured by Acceptability for Participants Questionnaire

    Acceptability of rocking or sitting after hip arthroplasty indicated by score on domains of affective, perceived effectiveness, intervention coherence, ethicality, burden, opportunity costs, self-efficacy likert scales from 1-4 (Not at all, a little, somewhat, very much). Scores from each domain are combined and summed to determine a single acceptability score (higher scores equate to higher acceptability of the intervention).

    Time frame: From enrollment to 31-day follow-up

Secondary outcomes

  1. Total participants indicating Nausea using the PROMIS Scale v1.0 GI Nausea and Vomiting 4A

    Participants indicate Daily nausea assessment on 5-point Likert scale (never, rarely, sometimes, often, always). Higher scores indicate more Nausea.

    Time frame: From surgery (Day 1 of the study) to 31-day follow-up

  2. Total participants reporting Gas/bloating via PROMIS v1.1 GI Gas and Bloating 13A

    Participants reporting Daily gas/bloating assessment on 5-point Likert scale (not at all, a little bit, somewhat, quite a bit, very much). Higher scores indicate more daily gas/bloating.

    Time frame: From surgery (Day 1 of the study) to end of 31-day follow-up

  3. Total participants reporting Daily pain assessed by PROMIS v2.0 pain intensity 3A

    Participants reporting Daily pain assessment on 5-point likert scale (no pain, mild, moderate, severe, very severe). Higher scores equate to more daily pain experienced.

    Time frame: From surgery (Day 1 of the study) to end of 31-day follow-up

  4. Total amount of participants' Daily Ambulation as measured using steps via activPAL4pro accelerometer

    The amount of participants' Daily ambulation will be assessed with the amount of steps taken per day using the triaxial accelerometer activPAL4pro. More steps per day equates to greater ambulation.

    Time frame: After surgery (Day 1 of the study) and up to 7 days post-surgery

  5. Total amount of participants' Daily anxiety measured using the Anxiety subscale of the Neuro-QoL Hospital Anxiety and Depression Scale

    The participants will report their Daily anxiety assessment using the Anxiety subscale of the Neuro-QoL Hospital Anxiety and Depression Scale, which assesses self-reported fear, worry, tension, and nervousness and will be scored with a T-score with higher scores indicating more anxiety. The scores range from 0-3 (not at all, not often, sometimes, most of the time).

    Time frame: From enrollment through 31-day follow-up

  6. Participants' self-reported Additional healthcare visits since their surgery, as assessed via phone call at 31-days post-surgery

    The total number of Additional healthcare visits will be assessed via phone call at 31-days post-surgery using the investigator-developed question: Have you been hospitalized since you have been discharged from your hip surgery?

    Time frame: From surgery (Day 1 of the study) until 31-day follow-up

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes — Will provide de-identified data to other researchers if a reasonable request is made

Supporting information: Study protocol

Time frame: Start date: March 2026 End date: up to 7 years after study ends

Access criteria: Study investigators will be able to access the IPD after it has been de-identified. They will access via password protected files.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for May 2026; primary completion for Sep 2026, 4 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 9, 2026
First posted
Apr 22, 2026
StartEst.
May 15, 2026
Primary completionEst.
Sep 30, 2026
CompletionEst.
Oct 31, 2026
Last update
Apr 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07544550
Lead sponsor
University of Missouri, Kansas City
Collaborators
Sigma-Tau Research, Inc., Association of Rehabilitation Nurses
Responsible party
Matthew Chrisman (Associate Professor, University of Missouri, Kansas City) — Principal investigator
First posted
Apr 22, 2026
Start date
May 15, 2026 (estimated)
Primary completion
Sep 30, 2026 (estimated)
Completion
Oct 31, 2026 (estimated)
Last update
Apr 27, 2026

Study contacts

Amelia Hopper, MSN
Contact
amhkk9@umkc.edu
816-235-5700
Matthew Chrisman, PHD
study chair · University of Missouri, Kansas City

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion